Patent · US Active

Site specific delivery of nucleic acids by combining targeting ligands with endosomolytic components

US9345780B2 · kind B2 · utility

237Cited by
5References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 1, 2013
Grant dateMay 24, 2016
Priority date
Expiry dateOct 1, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/32
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to compositions and methods for site-specific delivery of nucleic acids by combining them with targeting ligands and endosomolytic components.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.